Elevated Hsp90 expression has been documented in breast ductal carcinomas [44,45,46,47,48], whilst a significantly decreased Hsp90 expression has been shown in infiltrative lobular carcinomas and lobular neoplasia [49,50]. Here, HSP90AB1 is linked to lobular neoplasia.